Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin vs Crisugabalin in Fibromyalgia
NCT07196657Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Sep 2025
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of crisugabalin besilate in fibromyalgia (FM) (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Proportion of patients achieving pain relief at 12 weeks. Started Sep 2025; status: recruiting.
02
Drugs
crisugabalin besilate
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT07196657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07196657.